The fact that the International Multiple Sclerosis Genetics Consortium had reported an association between CD161 genetic variants and the disease [69] and that differences in CD161 expression were detected in MS-discordant monozygotic twins, suggested that this alteration affected MS risk through a complex interaction between heritable and non-heritable factors. This evidence concerns the gene KLRB1 and myeloid sarcoma.